key: cord-0697959-7yct2t4k
authors: Doctor, Pezad N.; Kamat, Deepak; Sood, Beena G.
title: Changes in Clinical Care of the Newborn during COVID 19 Pandemic: From the Womb to First Newborn Visit
date: 2021-05-19
journal: Pediatr Clin North Am
DOI: 10.1016/j.pcl.2021.05.008
sha: 809021f10ecd8b883ce44bf05a5357a458730a64
doc_id: 697959
cord_uid: 7yct2t4k

Coronavirus Disease of 2019 (COVID-19) has afflicted the health of women and children across all age groups. Since the outbreak of the pandemic in December 2019, various epidemiological, immunologic, clinical and pharmaceutical studies have been conducted across the world to understand its infectious characteristics, pathogenesis and clinical profile in affected individuals, with the hope of improving outcomes and ultimately leading to the development of vaccinations. COVID-19 has shown to affect pregnant women more seriously than non-pregnant women, endangering the health of the newborn. Various changes in the guidelines have been implemented in antenatal care of pregnant women, their delivery as well as newborn care during the COVID-19 pandemic, with the hope of reducing the risk of viral transmission and, in turn, improve outcomes in pregnant women and children. In this review, we highlight the current trends of clinical care in pregnant women and newborn during COVID 19 pandemic

mortality. SARS-CoV2 has been demonstrated to be transmitted by respiratory droplets, contact, and fomites [3] [4] [5] . SARS-CoV2 has proven to be highly contagious with a reproduction number of 2.2 to 5.7 which means than 1 person with SARS-CoV2 infection can infect on an average 2 to 5 people around him or her if no precautions were followed 6 . SARS-CoV2 gains entry into the lungs and gut by binding to the angiotensin-converting enzyme receptor 2 (ACE II) present abundantly on the type 2 pneumocytes and gastrointestinal epithelium. There is controversy regarding in-utero transmission of SARS-CoV2. However, there is increasing evidence of horizontal transmission from mother to neonate. There is a scarcity of data regarding pregnant women affected with COVID-19, and its implications during pregnancy: prenatal visits, antenatal scans, testing, and management of symptomatic women, delivery as well as delivery room preparedness, logistics and post-natal care of newborns [7] [8] [9] [10] . In this review, we highlight major changes in clinical practice implemented during delivery and post-natal care of newborns born to mothers with confirmed or suspected SARS-CoV-2 infection during the pandemic, based on various expert opinions and evolving evidence.

Early speculations regarding SARS-CoV2 infection in pregnancy were concerning due to changes in cellular immunity during pregnancy along with an array of physiological changes in cardiovascular, respiratory and coagulation systems. Few studies have investigated if SARS-CoV2 infection poses additional risk during pregnancy 11 . Studies so far have shown similar COVID-19 symptoms in pregnant and non-pregnant women 12, 13 . Surveillance data from CDC including 91,412 women of reproductive age group (15 -45 years of age) with laboratoryconfirmed SARS-CoV2 infection showed no difference between pregnant (8, 207 ) and nonpregnant women (83, 205) in terms of cough and shortness of breath 14 . Headache, fever, chills, J o u r n a l P r e -p r o o f diarrhea and muscle aches were in fact less frequently noted in pregnant women compared to non-pregnant women. Initial studies from New York, showed a significant number of asymptomatic carrier rate (up to 33%) in pregnant women 15, 16 . Therefore, universal screening for SARS-CoV2 infection in all pregnant women during hospitalization or at the time of delivery was proposed and soon became the standard of care. In a series of 54 pregnant women with confirmed (n=38) and suspected (n=16) SARS-CoV2 infections reported by Sentilhes et al, oxygen supplementation was required in 24.1%, ICU admission in 9.3%, and severe illness was observed in those over the age of 35 years or those with co-morbidities such as asthma and obesity 17 . In a recent report by CDC's Coronavirus Disease 19-Associated Hospitalization Surveillance Network (COVID-NET) surveillance team found that of the 598 pregnant women hospitalized in 13 states across the country with COVID-19 between March 1 st and August 22 nd , 2020, the majority of them (55%) were asymptomatic 18 . However, severe illness was observed in symptomatic women that included intensive care admission in 16%, mechanical ventilation in 8% and mortality in 1% 18 . In an analysis of approximately 400,000 women aged 15-44 years with symptomatic COVID-19 by the CDC's Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), intensive care unit admission, invasive ventilation, extracorporeal membrane oxygenation, and death were more likely in pregnant women than in nonpregnant women 19 . In a 35-year-old woman infected with COVID-19, placental pathology showed inflammation and presence of SARS-CoV2 by immunohistochemistry at 22 weeks gestation, possibly contributing to development of early onset preeclampsia, hypertension and disseminated coagulopathy 20 . Hence, a multidisciplinary team of maternal fetal medicine specialists and neonatologists is essential in the care of pregnant women with SARS Cov-2 infection and their infants J o u r n a l P r e -p r o o f

Since the declaration of SARS-CoV2 as a pandemic by World health Organization (WHO), the American College of Obstetrics and Gynecology (ACOG) has proposed various modifications in the existing guidelines of antenatal visits and ultrasounds. These modifications were primarily made to reduce the contact between the pregnant women and health care facilities as well as to reduce the transmission of SARS-CoV2 throughout the general population 21 . Minimal data is available on the impact on maternal and fetal health following guideline changes. In a 28-yearold pregnant woman with gestational diabetes mellitus and chronic hypertension who was found to be COVID-19 positive at 34 weeks gestation, her routine non-stress testing (NST) and amniotic fluid index (AFI) testing were delayed due to COVID-19 positive status. Ultimately, her NST revealed category 2 tracing persistently, requiring urgent cesarean section 22 . This case highlights that the frequency of antenatal visits and testing should be decided on an individualized basis, especially for high-risk pregnancies.

The first case of SARS-CoV2 infection in a neonate was reported in February 2020. The infant presented at 17 days of age with fever, cough runny nose and vomiting 23 . This led to suspicion of vertical transmission in utero as the mother of the newborn was tested positive for SARS-CoV2.

Early studies conducted in China were unable to isolate SARS-CoV2 from amniotic fluid, vaginal mucus, cord blood, placenta, urine, feces and breast milk. Similarly, Silva et al did not find SARS-CoV2 by RT-PCR in 18 samples of amniotic fluid, umbilical cord and placental obtained from COVID-19 positive mothers 24 . Therefore, the risk of vertical transmission was considered highly unlikely [25] [26] [27] [28] [29] . However, in a retrospective cohort study of 3497 respiratory, urine, stool and serum samples from adults analyzed for SARS-CoV2 viral load, the median J o u r n a l P r e -p r o o f duration of the virus in stools (22 days, interquartile range 17-31 days) was significantly longer than in respiratory (18 days, 13-29 days; P=0.02) and serum samples (16 days, 11-21 days; p <0.001) 30 . In a study by Zeng et 

The US Food and Drug Administration recently approved two vaccines against SARS-CoV2 have recommended their use in pregnant and lactating women 35, 36 . However, there data is lacking regarding the benefits (to the mother and trans placental passage of passive immunity to the fetus) and side-effects of these vaccines in this subset of patients as pregnant women were not involved in the studies during vaccine development 37 . In a study by Flannery and colleagues J o u r n a l P r e -p r o o f involving 1714 mothers who delivered from April to August 2020 in northeastern United States, 83 (6%) had detectable IgG and/or IgM antibodies at delivery. However, majority of infants born to these seropositive mothers (72/83) has detectable IgG levels at birth suggesting transplacental transfer during pregnancy 38 . For Moderna mRNA-1273 vaccine, the WHO revised the recommendation on January 29 th , 2021 stating "pregnant women at high risk of exposure to SARS CoV-2 (e.g. health workers) or who have comorbidities which add to their risk of severe disease, may be vaccinated in consultation with their health care provider" 39 . While immunization may be the best available options for pregnant and lactating mothers to protect themselves and their infant, longitudinal clinical studies are necessary to implement safe vaccination guidelines.

Much of delivery room preparedness recommendations depended upon the COVID-19 status of the mother. Therefore, short turnaround time of the test was crucial for optimal preparedness during delivery. If resources were available, all mothers were tested for SARS-CoV2 at delivery irrespective of their clinical profile to prevent nosocomial spread to other patients and health care workers 40 . All mothers whose COVID-19 status was unknown either due to lack of resources, testing refusal or in whom the test results were not back by the time they delivered were considered positive due to the high asymptomatic carrier state 15 . Important aspects of delivery room preparedness included availability of N95 masks, appropriate personal protective equipment, medical professional experienced in neonatal resuscitation to minimize aerosolization during newborn resuscitation, and separation of the mother from the newborn 15, 40 . Discussion and planning between the obstetric and neonatal teams guided maternal and newborn care such J o u r n a l P r e -p r o o f use of maternal steroids (dexamethasone for COVID-19 related lung injury in mother vs.

betamethasone for fetal lung maturity), magnesium sulfate for preterm delivery, unfractionated heparin for thromboembolism prophylaxis and use of remdesvir 41 . Positive pressure ventilation using bag and mask, endotracheal intubations and high flow nasal cannula have the potential to aerosolize the respiratory droplets, allowing SARS-CoV2 to remain in air for > 3hr and propagate > 2 meters 42 . Pregnant women who are COVID-19 positive or unknown should deliver preferably in negative pressure room, if available, with an adjoining room for neonatal resuscitation 40, 43, 44 . If not available, a single room with minimal entry and exit of essential caregiver from the room is paramount 43, 44 . Earlier, delayed cord clamping was deferred due to the unknown risk of vertical transmission 8 

Varied speculations have been made on the mode of delivery in pregnant women with SARS-CoV2 46-49 . Cesarean section was performed for routine obstetric indications or worsening respiratory distress and exhaustion due to COVID-19 40 . Some centers also preferred cesarean section for reducing the total hospital stay of the mother and to minimize cross-infection 40, 47 .

However, in a case reported by Iqbal et al., a full-term female infant who was born by vaginal delivery to a SARS-CoV2 infected mother was asymptomatic and discharged home on the 6 th day of life 48 . A retrospective cohort study among adults found that SARS-CoV2 was present in stool samples for a longer duration compared to serum and respiratory mucosa 30 China and around the world affecting newborns as early as few hours, separation of the mother with suspected or confirmed SARS-CoV2 from newborn was strongly recommended by other health organizations such as AAP, ACOG and CDC 43, 45, 62 . However, separation may not be always feasible due to the lack of infrastructure and resources available in other parts of the world. Recent amendments in the CDCs guidelines allow a case-by-case approach and takes into account decision made between the health care provider and mother, the clinical condition of the J o u r n a l P r e -p r o o f mother and infant, availability of testing, staffing, space, PPE and test results of the newborn 62 .

As of August 3 rd , 2020, the CDC recommends mothers to remain separated for at least 10 days since the appearance of first symptoms (20 days if critically ill or immunocompromised mother), and at least 24 hours since the last fever without use of antipyretics and improvement in other symptoms 62 . If the newborn is tested COVID-19 positive, there is no need for separation. If the mother refuses separation, the newborn and mother should be placed in a negative pressure room with ≥ 6 feet distance between the two. In addition, the newborn should be placed in a temperature-regulated isolette to minimize droplet spread from mother. The Italian Society of Neonatology guidelines endorsed by the Union of European Neonatal and Perinatal Societies (UENPS) suggest that rooming-in of mother and newborn is workable if a mother is SARS-CoV-2 positive or is a person under investigation (PUI), or is asymptomatic or has minimal symptoms at delivery, but with strict infection control measures 63 . Ample research-based evidence has concluded that early maternal-newborn bonding positively impacts the growth and development in term and pre-term neonates 64, 65 . Early separation may negatively affect bonding, breast milk production and mental health of the mother during the hospital stay and after discharge with uncertain short-and long-term implications. In a recent study of 45 newborns born to SARS-CoV2 positive mothers, 33 (73%) roomed-in with mother. Thirty-one of the 33 newborns were breastfed within the 1 hour of birth. All 33 newborns were tested negative for SARS-CoV2, did not require NICU admission and remained asymptomatic at their 2-week telemedicine follow up visit 66 .

Various clinical studies have concluded that newborns and infants are less susceptible to SARS-CoV2 infection and have a fairly mild clinical course with lower mortality compared to adults.

Few theories have been proposed explaining this difference in clinical susceptibility. These include immature angiotensin-converting enzyme receptor 2 (ACE II) in neonates which may prevent or reduce binding of the virus to the epithelial cells and naïve immune system of newborn mounting a poor inflammatory response 67, 68 . However, the exact pathogenesis of COVID-19 is still being investigated. Neonates and children are usually asymptomatic or develop mild symptoms such as respiratory distress and feeding difficulties. A clinical finding of COVID-19 specific to newborns has not been recognized. The first few case series from China reported that majority of newborns born to SARS-CoV2 confirmed mothers were unaffected 25, 26 .

Later, few publications reported varied presentations such as respiratory distress, shock, tachycardia, sepsis, thrombocytopenia and occasionally death in neonates 8, 9, 32, 69 . Other presenting symptoms include temperature instability, poor feeding, diarrhea, vomiting and abdominal distension. Associated risk factors such as prematurity, prolonged rupture of membranes and sepsis were also present in these neonates. In another case series of four neonates ranging between 30 hours and 17 days with confirmed SARS-CoV2 positive by nucleic acid testing, 2 had fever, 1 developed respiratory distress, 1 had cough and 1 had no symptoms 69 73 . Clinical findings included fever in 50%, gastrointestinal symptoms in 26%, hypoxia in 20% and cough in 20%. All newborns were discharged home after a median (IQR) length of stay of 10 (6-14) days 73 . In a study by the national surveillance registry of UK that included 66 newborns who tested positive, 16 (24%) were born preterm. The incidence of SARS-CoV2 was estimated to be 5.6 per 10,000 live births.

The most common symptoms were hyperthermia (35%), poor feeding/vomiting (33%) and coryza (26%). In terms of respiratory support, 33% required supplemental oxygen, 15% required non-invasive ventilation and 5% required intubation 74 . In a large single study in New York including 101 newborns born to SARS-CoV2 positive mothers, maternal severe/critical COVID-19 disease was associated with birth approximately 1 week before the due date (median 

In February 2020, the Chinese Perinatal-neonatal 2019-nCoV Committee proposed the definition of suspected and confirmed neonatal cases after a systematic review of current and previous literature in their consensus statement.

All newborn born to SARS-CoV2 confirmed mother within 14 days before birth and 28 days after birth or newborns exposed directly to SARS-CoV2 infected individuals (including family members, caregivers, medical staff, and visitors) are considered to be suspected cases 8 .

Newborn in whom respiratory tract or blood specimens tested by RT-PCR are positive for SARS-CoV2; OR Virus gene sequencing of the respiratory tract or blood specimens is highly homologous to that of the known SARS-CoV2 specimens 8 . Radiological findings in newborns are not specific and may include ground glass opacities, unilateral and bilateral sub-segmental opacities and pneumothorax 8, 9, 26 . In a national surveillance registry of UK, of the 26 newborns who were SARS-CoV2 positive that had chest radiograms, 14 (56%) had abnormal findings, with ground-glass changes reported in seven (28%) and 4 of these 7 babies were born preterm 74 .

In April 2020, the Vermont Oxford Network, VON, in partnership with the American Academy of Pediatrics Section on Neonatal Perinatal Medicine (SONPM) conducted an audit to assess the impact of SARS-CoV2 on neonates and their families 83 . Of the 332 hospitals, 54% reported shortages of equipment, testing, or personnel; 73% reported minor disruptions to care for infants and families and 3% reported an inability to provide care to some, most, or all infants 82 . Due to ever-evolving evidence of SARS-CoV2 transmission between asymptomatic carriers, varying policy changes have been made by many NICUs and newborn nurseries across the world to limit the entry of healthy family members. Due to vulnerability of the infant's health in the NICU, the AAP recommends restricting parents and family members with COVID-19 for 14 to 20 days from onset of disease symptoms or first positive test 45 . Some NICUs made strict visitation policies with exceptions on a case-by-case basis. This led to disparities in the NICU visitation by family members and lack of parental participation in family-centered rounds 83 . The AAP strongly advocated that "any policy restricting visitors for pediatric patients should be applied equally regardless of children's race, ethnicity, socioeconomic status, culture, and religion" to J o u r n a l P r e -p r o o f minimize health disparities 84 . Nonetheless, various social, emotional and psychological challenges were faced by family members during the separation of neonates staying for extended duration in the NICU 83 . Parental stress arising from NICU admission has been associated with poor neurodevelopmental outcomes in preterm babies 85 . Especially in the pandemic, parental stress can worsen due to restricted visitation. Due to growing evidence of low transmission risk in the NICU, these restrictions have been alleviated to some extent in most NICUs and newborn nurseries across the country 86 . In a center where universal screening of neonates, parents and staff was practiced, no SARS-CoV2 infection among the neonates admitted to the NICU was noted in an area with a high incidence of SARS-CoV-2 87 . If parental visitation is restricted, the NICU should provide numerous ways to best support infants and their families to cope during stressful environment 88 . As the literature on SARS-COV2 in neonates accumulates, evidencebased policies should be formulated to prevent horizontal spread of SARS-CoV2 in the NICU that can be applicable universally 89 .

Routine newborn care including physical examination, vitamin K injection, administration of erythromycin eye ointment, performing hearing and critical congenital heart disease screen and administering hepatitis B vaccine per the institutional policies should be completed before discharge irrespective of SARS-CoV-2 testing. If the newborn is tests positive, remains positive on repeat testing and is asymptomatic, then the newborn can be discharged with home quarantine for 10 days from the first positive test 45 . Care should be taken to prevent spread from the newborn to other members at home. Newborn visits can be arranged by telemedicine or phone.

In-office visits should be avoided as far as possible to prevent spread. Some hospital centers, through charitable organizations, have been arranging and distributing electronic scales at J o u r n a l P r e -p r o o f discharge for assessing weight gain at home 40 . This may reduce the need for newborn in-office visits. If an in-office visit is necessary, parents should inform the clinic about the COVID-19 status of the newborn and the accompanying parent before arrival so that necessary precautions can be in place at the pediatrician's office. If the newborn is tested negative at discharge, then thorough parental counseling and additional infection prevention education should be provided to all the possible caregivers and household members after discharge. Other household members who may have been exposed to COVID-19 should maintain ≥ 6 feet distance with the use of facemask and adequate hand hygiene 45 . In a cohort analysis of 101 neonates born to mothers with perinatal SARS-CoV2 infections at a single institution in New York, 55 who were seen at the newborn COVID-19 follow up clinic remained healthy at 2 weeks of life. The appropriate duration of infection control practiced by the breastfeeding mother is unknown as a varying duration of viral shedding has been shown from different sites 30 . However, the AAP recommends that infection control be practiced for at least 10 days from the onset of symptoms and at least 24 hours since being afebrile without antipyretics 7 . Other precautionary measures as mentioned above should be followed by mothers while breastfeeding. Parents should be educated regarding normal newborn care and common red flags concerning illness in newborns 45 . J o u r n a l P r e -p r o o f

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases : IJID : official publication of the International Society for

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions

American Academy of Pediatrics Committee on Fetus and Newborn, Section of Neonatal-Perinatal Medicine & Committee on Infectious Disease. Initial guidance: management of infants born to mothers with COVID-19

Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection

Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China

COVID-19 and Neonatal Respiratory Care: Current Evidence and Practical Approach

Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review

Pneumonia and pregnancy

An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of pathology & laboratory medicine

Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States

Delivery Room Preparedness and Early Neonatal Outcomes During COVID-19 Pandemic

Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth

Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 -COVID-NET, 13 States

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States

SARS-CoV-2 infection of the placenta

MFM guidance for COVID-19

Urgent Cesarean Delivery Following Nonstress Test in a Patient with COVID-19 and Pregestational Diabetes

Is SARS-CoV-2 Vertically Transmitted?

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia

Perinatal Transmission of 2019 Coronavirus Disease-Associated Severe Acute Respiratory Syndrome Coronavirus 2: Should We Worry? Clinical Infectious Diseases

Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients

Coronavirus in pregnancy and delivery: rapid review

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China

Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn

Clinical infectious diseases : an official publication of the Infectious Diseases Society of

NPC-19 Registry update: AAP SONPM National Registry of Perinatal COVID 19 infection

Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy -SET-NET, 16 Jurisdictions

COVID-19 ACIP vaccine recommendations

American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group. Practice Advisory. Vaccinating Pregnant and Lactating Patients Against COVID-19

COVID-19 Vaccination in Pregnant and Lactating Women

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios

The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know

Management of newborns exposed to mothers with confirmed or suspected COVID-19

Perinatal Maternal-Fetal/Neonatal Transmission of COVID-19: A Guide to Safe Maternal and Neonatal Care in the Era of COVID-19 and Physical Distancing

Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV

American College of Obstetricians and Gynecologists. COVID-19 FAQs for Obstetrician-Gynecologists

Ovalı F. SARS-CoV-2 Infection and the Newborn

Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province

Safe delivery for pregnancies affected by COVID-19

An Uncomplicated Delivery in a Patient with Covid-19 in the United States

COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes

Pregnancy, Breastfeeding, and Caring for Newborns

World Health Organization. Breastfeeding advice during the COVID-19 outbreak

Breastfeeding and coronavirus disease-2019: Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies

Best Practices for COVID-19-Positive or Exposed Mothers-Breastfeeding and Pumping Milk

Clinical characteristics of 19 neonates born to mothers with COVID-19

Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2

Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding

Detection of SARS-CoV-2 in human breastmilk

An Uninfected Preterm Newborn Inadvertently Fed SARS-CoV-2-Positive Breast Milk

Detection of SARS-CoV-2 in Milk From COVID-19 Positive Mothers and Follow-Up of Their Infants

Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products

Interim considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings

Union of European Neonatal and Perinatal Societies

Investigating skin-to-skin care patterns with extremely preterm infants in the NICU and their effect on early cognitive and communication performance: a retrospective cohort study

Associations Between Nurse-Guided Variables and Plasma Oxytocin Trajectories in Premature Infants During Initial Hospitalization

Newborns of COVID-19 mothers: short-term outcomes of colocating and breastfeeding from the pandemic's epicenter

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19

Novel coronavirus infection in newborn babies aged <28 days in China

Neonatal SARS-CoV-2 May Present With Hypoxemia Without Respiratory Distress

Epidemiology of COVID-19 Among Children in China

The clinical course of SARS-CoV-2 positive neonates

Coronavirus infection in neonates: a systematic review

Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. The Lancet Child & Adolescent Health

Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center

Fetal Inflammatory Response Syndrome Associated with Maternal SARS-CoV-2 Infection

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study

Caring for Newborns Born to Mothers With COVID-19: More Questions Than Answers

Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists

Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association

Evaluation and Management Considerations for Neonates At Risk for COVID-19

COVID-19 and Newborn Care

Advancing Health Equity by Translating Lessons Learned from NICU Family Visitations During the COVID-19 Pandemic

Benefits and Risks of Visitor Restrictions for Hospitalized Children During the COVID Pandemic

The interplay between prematurity, maternal stress and children's intelligence quotient at age 11: A longitudinal study

Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study

Universal screening of high-risk neonates, parents, and staff at a neonatal intensive care unit during the SARS-CoV-2 pandemic

Visitation restrictions: is it right and how do we support families in the NICU during COVID-19?

COVID-19 surveillance for all newborns at the NICU; conditio sine qua non?